Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BUCHI is a Swiss laboratory technology company that develops and sells instruments and process solutions for research and development, quality control, and production workflows. The company is best known for evaporation systems such as the Rotavapor®, and also offers products for chromatography, spray drying, freeze drying, extraction, Kjeldahl analysis, NIR spectroscopy, melting point analysis, encapsulation, and related laboratory services. Its customer base spans pharmaceutical, chemical, food and feed, beverage, environmental, and academic laboratories. While BUCHI is not a drug developer, it is highly relevant to life sciences because its equipment is widely used in pharmaceutical and chemical R&D, analytical testing, and production support. The company is family-owned, globally active, headquartered in Flawil, Switzerland, and operates as a long-established commercial supplier of lab instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Buchi Labortechnik.